No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Fatty Acid Receptor (FAR) market is a subset of the Proteomics market, which focuses on the study of proteins and their functions. FARs are a family of proteins that bind to fatty acids and play a role in the regulation of metabolic processes. They are involved in a variety of physiological processes, including inflammation, energy metabolism, and cell signaling. FARs are also involved in the development of diseases such as obesity, diabetes, and cancer.
The FAR market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of new technologies for drug discovery. Companies in the FAR market are focused on developing novel therapeutics and diagnostics for diseases related to FARs. These companies are also involved in the development of new technologies for drug discovery and biomarker identification.
Some of the major companies in the FAR market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
